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Summary
Association or linkage studies involving control and
long-lived populations provide information on genes
that influence longevity. However, the relationship be-
tween allele-specific differences in survival and the ge-
netic structure of aging cohorts remains unclear. We
model a heterogeneous cohort comprising several gen-
otypes differing in age-specific mortality. In its most gen-
eral form, without any specific assumption regarding the
shape of mortality curves, the model permits derivation
of a fundamental property underlying abrupt age-related
changes in the composition of a cohort. The model is
applied to sex-specific survival curves taken from period
life tables, and Gompertz-Makeham mortality coeffi-
cients are calculated for the French population. Then,
adjustments are performed under Gompertz-Makeham
mortality functions for three genotypes composing a het-
erogeneous cohort, under the constraint of fitting the
resultant mortality to the real French population mor-
tality obtained from life tables. Multimodal curves and
divergence after the 8th decade appear as recurrent fea-
tures of the frequency trajectories. Finally, a fit to data
previously obtained at the angiotensin-converting–
enzyme locus is realized, explaining what had seemed
to be paradoxical results—namely, that the frequency of
a genotype known as a cardiovascular risk factor was
increased in centenarians. Our results help explain the
well-documented departure from Gompertz-Makeham
mortality kinetics at older ages. The implications of our
model are discussed in the context of known genetic
effects on human longevity and age-related pathologies.
Since antagonistic pleiotropy between early and late sur-
vival emerges as a general rule, extrapolating the effects
measured for a gene in a particular age class to other
ages could be misleading.
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Introduction
Genetic influences on human longevity have been widely
documented, and rapid progress in human genome map-
ping renders the project of trying to sort out these in-
fluences feasible (Scha¨chter et al. 1993). Differential sur-
vival values of polymorphic genes must result in a
reshaping, with age, of the genetic structure of any pop-
ulation, so that, after mortality selection, the population
of “survivors,” whose genetic composition should pro-
vide information on genetic factors relevant to survival,
remains. The Chronos collection of French centenarians
currently includes 1800 subjects who were x99 years
of age when first recorded, therefore providing a useful
population in which to search for genes associated with
longevity.
Association studies to identify genetic components of
longevity rely on a comparison between two age groups
and ignore intervening dynamics. In contrast with dis-
eases for which epidemiological features such as odds
ratios or relative risks are calculated for restricted age
classes, longevity is a quantitative trait that integrates
all prior influences on survival. Demographic ap-
proaches, which emphasize the relationships between
death rates and age classes for different populations at
different periods, are therefore appropriate. Reconstruc-
tion of life tables from census data provides precise es-
timates of age-specific quantities such as survival, mor-
tality, and life expectancy. These data generally ignore
interindividual variability, except, usually, that of gender.
Known genetic risk factors for major age-related pa-
thologies are obvious candidates for genetic components
of longevity. With increasing age, such factors should
progressively disappear from cohorts. However, since
longevity is the net outcome of cumulative mortality over
all age classes, this conclusion is not necessarily war-
ranted for genes with age-specific effects. Indeed, a cen-
tral feature of evolutionary theories of aging is antag-
onistic pleiotropy, meaning opposite effects of the same
allele at different ages (Williams 1957). At the cohort
level, genetic variation in survival potential is likely to
have a greater impact on the genotypic composition of
a cohort later in life, as the selection gradient becomes
1526 Am. J. Hum. Genet. 62:1525–1534, 1998
steeper because of increasing mortality. Our goal in this
study is to provide mathematical support for this intu-
itive notion and to assess the relationship between mor-
tality and age-dependent changes in the genetic com-
position of a heterogeneous cohort. We investigate a
simple genetic model and show that general assumptions
are sufficient to generate complex dynamics and antag-
onistic pleiotropy for mortality.
Methods
I. Basic Model
Consider a cohort composed of n different genotypes.
Let Ni0 be the number of individuals of genotype i at an
initial age x0. The initial number of individuals in the
cohort is .N¯  N0 i0
The survival function si(x) of genotype i is the pro-
portion of the initial Ni0 individuals surviving at age x:
, where Ni(x) is the number of survivorss (x)  N (x)/Ni i i0
of genotype i at age x. Similarly, the overall survival
function of the cohort is , where¯ ¯s¯(x)  N(x)/N0
is the total number of survivors at ageN¯(x)  N (x)i
x.
The initial structure of the cohort is defined by the
proportion fi0 of each genotype i in the cohort at age x0:
. Similarly, the frequency fi(x) of genotype i¯f  N /Ni0 i0 0
at age x is
N (x) s (x)i if (x)   f . (1)i i0¯ ¯N(x) s(x)
Age-specific mortality associated with genotypes may be
defined either as forces of mortality or as probabilities
of death. The conditional probability of death for ge-
notype i in the age interval , given sur-[x, x h)(h 1 0)
vival to age x, is
s (x h)iq  1 , (2)h ix s (x)i
which is usually denoted as “qix” for .h  1
The force-of-mortality function of genotype i is an
instantaneous measure of mortality at age x and is de-
fined on the basis of equation (2):
q d s (x)h ix i
m (x)  lim   . (3)i h s (x) dxhr0 i
We may notice that, unlike the force-of-mortality func-
tion mi(x), the conditional probability hqix is up-bounded
by 1. When mortality is low, mi(x) is small and can be
approximated by qix.
Integration of equation (3) yields
x
s (x)  exp  m (y)dy . (4)i  i[ ]
yx0
The overall force-of-mortality function, age-specific
probability of death, and survival function are the
weighted means of the corresponding genotype-specific
functions:
m(x)  f (x) m (x) , (5)¯  i i
q¯  f (x) q , (6)x i ix
and
s¯(x)  f s (x) . (7) i0 i
II. Variation of Genotypic Frequencies
Changes in the frequency trajectory of genotype i in
the cohort are described by changes of the sign of the
first derivative of fi(x). From equations (1), (3), (5), and
(7), it is immediately clear that
d f (x)i [ ] f (x) m(x) m (x) (8)¯i idx
or
d log[f (x)]i  m(x) m (x) ,¯ idx
which, when the frequencies of two genotypes, i and j,
are compared, is also equivalent to
f (x)id log[ ]f (x) d{log[s (x)] log[s (x)]}j i j
dx dx
 m (x) m (x) . (9)j i
III. Age-Specific Mortality Data
Age-specific mortality data were obtained from the
complete-period life tables for the French population in
1990–92 (INSEE 1993), which provide conditional
probabilities of death, qx, and survival functions, s(x),
for males, females, and the overall population, on a 1-
year scale, for ages 0–100 years. For ages 1100 years,
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life tables from the Fondation Institut de Produits de
Synthe`se et d’Extraction Naturelle (Fondation IPSEN)
survey (Allard et al. 1993) were used.
A heterogeneous cohort composed of males and fe-
males exhibiting these age-specific mortalities was built.
The change, with age, of the frequencies of males and
females (eq. [1]) was calculated by use of the survival-
functions data, si(x) for both sexes and with the as-
sumption that the initial frequencies (fi0) at birth (x0 
0 years) were .512 for males and .488 for females. The
overall survival function was calculated from equation
(7).
IV. Assumption of Gompertz-Makeham Model for
Mortality
For a wide variety of human and animal populations,
age-specific mortality after maturation is well modeled
by the Gompertz-Makeham equation (Sacher 1977;
Comfort 1979; Finch 1990; Gavrilov and Gavrilova
1991). Force-of-mortality functions may then be written
as
m(x)  m a exp (ax) , (10)
where m is the background mortality and a and a are
two age-independent parameters corresponding, respec-
tively, to the initial mortality and the exponential co-
efficient of mortality increase. This model accounts for
the phenomenon of senescence in adults–that is, the ac-
celeration of mortality, with age, after maturity.
With the notations previously introduced in the model
of heterogeneous cohorts, equation (10) becomes
m (x)  m a exp (a x) , (11)i i i
where the index i denotes a given genotype. We assumed
that the background mortality m was genotype inde-
pendent. Integrating equation (11) into equation (4)
yields
ais (x)  exp [exp (a x ) exp (a x)]i i 0 i{a i
m(x  x) . (12)0 }
Within the framework of equation (11), different situ-
ations could be modeled, depending on the independence
of the parameters for the genotypes. Equations with
equal ai and different ai parameters resulted in parallel
curves and constant relative risks between genotypes,
meaning that genetic variation induced only differing
initial mortalities and did not affect change, with age,
in mortality. Conversely, equations with equal ai and
different ai parameters resulted in diverging curves and
exponentially increasing relative risks among genotypes,
meaning that initial mortalities were identical but that
change in mortality with increasing age was genotype
dependent. Both hypotheses were used to account for
complex mortality patterns (Kowald and Kirkwood
1993; Vaupel and Carey 1993) but implied that the rel-
ative-risk status of genotypes remained qualitatively un-
changed throughout life—that is, a genotype causing del-
eterious effects at some age caused the same or even
worse effects later in life. More-interesting parameter
sets are thus obtained when both ai and ai are allowed
to differ among genotypes, accounting for the effects of
antagonistic pleiotropy on survival.
V. Estimation of Gompertz-Makeham Parameters for
French Mortality Data
Data on male, female, and overall-population age-spe-
cific mortalities in the French population in 1990–92
(Allard et al. 1993; INSEE 1993) were adjusted sepa-
rately to the Gompertz-Makeham model (eq. [10]). In
each case, the fittest set of parameters (a, a, and m) was
found by a nonlinear fitting procedure based on the gen-
eralized-reduced-gradient (GRG) method, as imple-
mented in GRG2 code (Lasdon et al. 1978). The algo-
rithm minimized the sum of squares of the differences
between logarithms of age-specific probabilities of death
data (qx-data) and the age-specific probabilities of death
(qx–Gompertz-Makeham) calculated from integration of equa-
tion (10): . Thex 22S [log(q ) log(q )]xx x-data x–Gompertz-Makeham1
fit was performed for the age range of x1 (age 20 years)
to x2 (either age 69 years or the maximum age available
in life tables [age 109 years for women and the overall
population and age 106 years for men]). Starting values
of the parameters were obtained by the linear method,
as described elsewhere (Gavrilov and Gavrilova 1991).
VI. Fit of a Heterogeneous Cohort’s Mortality to
Period Life Tables
The force-of-mortality functions and survival func-
tions of three genotypes (AA, BB, and AB) at a biallelic
locus were modeled according to the Gompertz-Make-
ham model (eqq. [11] and [12]). We assumed that the
genotypic structure was in Hardy-Weinberg equilibrium
at the initial age (x0  20 years) and that the three sets
of genotype-specific parameters (ai and ai) were inde-
pendent, in order to allow for possible antagonistic ef-
fects on survival. Under these assumptions, the genotypic
structure of the cohort at any age was completely de-
termined by eight parameters: one initial allelic fre-
quency, the genotype-independent background mortality
parameter (m), and the three genotype-specific sets of
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Figure 1 Survival curves from 1990–92 period French life tables,
showing separately males, females and their difference (females minus
males). a, Survival curves, linear scale. b, Survival curves, logarithmic
scale. The difference is the difference of the logarithms of survivals.
c, Sex-ratio (females / males) change and frequency trajectories of both
sexes in the same cohort.
two parameters (ai and ai). The GRG method described
above was used to find sets of these eight parameters
that minimized the sum of squares of the differences
between logarithms of the French-population age-spe-
cific probabilities of death data (qx–population data) and the
overall age-specific probabilities of death ( ), calculatedq¯x
from equation (6): ,x 22 ¯S [log(q ) log(q )]xx x–population data x1
with x1  20 years and x2  109 years. Starting values
of the seven parameters (m, ai, and ai) were set to the
corresponding estimations (m, a, and a) obtained for the
overall-population age-specific mortality data. Different
starting initial allelic frequencies were used.
VII. Fit to Angiotensin-Converting Enzyme (ACE) Data
The fitting algorithm described above was used to ob-
tain parameter sets in accordance with genotypic data
reported for the insertion/deletion (I/D) polymorphism
at the human ACE locus. Such adjustments were ob-
tained by addition of two constraints in the fitting
procedure:
1. The frequency trajectories of genotypes II, DD, and
ID were constrained to make them compatible with gen-
otypic frequencies observed in two age groups (Scha¨ch-
ter et al. 1994): adults (20–70 years old) and centenar-
ians. Because frequencies may vary dramatically across
narrow age intervals, especially at advanced ages, the
frequency of each genotype i in the modeled cohort, for
a given age interval, was calculated by
 s (x)i
f , (13)i0 ¯ s(x)
where the sums were calculated for every 1-year age
point in the age interval, according to equations (7) and
(12). The age intervals were 20–69 years and 99–119
years for the adult and centenarian groups, respectively.
A x2 distance between the observed genotypic numbers
(Scha¨chter et al. 1994) and the genotypic numbers cal-
culated from equation (13) was derived. A maximum of
this distance was set and used as a constraint in the fitting
procedure.
2. The force-of-mortality functions were constrained
to make them compatible with the odds ratios reported
for the myocardial infarction risk during middle age
(Tiret et al. 1993). In our model, the relative risks for
death were calculated as the ratios of the forces of mor-
tality at age 50 years: andRR  m (50)/m (50)DD/II DD II
. In the fitting procedure, theseRR  m (50)/m (50)ID/II ID II
values were bounded by the 95% confidence intervals
reported for the respective odds ratios: 1.2–5.6 and
0.9–3.9 for DD/II and ID/II, respectively.
Results
Changes, with Age, in Composition of a
Heterogeneous Cohort
The model developed in this paper considered a het-
erogeneous cohort composed of individuals that belong
to defined groups—for example, relevant geno-
types—differing in their susceptibility to death. Equation
(1) shows that the genotypic structure of the cohort at
any age could be deduced from the initial genotypic
structure and the survival functions associated with each
genotype and thus would be changed with age, as a result
of different mortalities among genotypes.
Two important properties concerning the age-related
dynamics of the cohort structure could be derived from
equations (8) and (9). First, as long as the difference
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Figure 2 Adjustment of the 1990–92 French females and males age-specific mortality data to Gompertz-Makeham equations on differently
fitting age ranges. Deviations between the observed and calculated curves are shown. a, Females fitting age range 20–69 years. b, Males fitting
age range 20–69 years. c, Females fitting age range 20–109 years. d, Males fitting age range 20–106 years.
between the mortalities of two genotypes retained the
same sign, the ratio of their frequencies was a monotonic
function of age. This property of divergence meant that
frequency ratios between any two genotypes increased
or decreased steadily with age if their mortality functions
did not intersect. The corollary of the first property was
that an extremum of the ratio between frequencies was
reached at the intersection point of the respective mor-
tality curves. Similarly, an absolute extremum of the ge-
notype frequency was reached when the genotype and
the overall mortality curves intersected. Such points
marked an inversion in the change in genotype frequen-
cies. If this occurred more than once for one genotype
relative to any other, its frequency exhibited a multi-
modal distribution with age. Equation (9) shows that
the difference between logarithms of survival functions,
rather than the difference between survival functions,
was relevant to frequency dynamics, so that it was of
interest to plot the curve of the former. This effect and
the divergence property are illustrated by variation in
the age-dependent sex ratio, as described below.
Age-Dependent Changes of the Sex Ratio
Figure 1 shows the survival curves extracted from the
1990–92-period life table for the French population (IN-
SEE 1993), both on a linear scale (fig. 1a) and on a
logarithmic scale (fig. 1b). The age-specific sex ratio in
a cohort was calculated from equation (1), by use of the
sex-specific survival-functions data. The sex ratio is a
monotonic function of age, with a very sharp increase
at older ages (fig. 1c). At age 100 years, the ratio is ∼
4:1, whereas the true ratio in a population of centenar-
ians is ∼7:1 (Allard et al. 1993). This excess of women
in the real population probably stems, however, from
extrinsic causes—such as wars—that have decimated the
male population and that were not taken into account
in the 1990–92-period life table. The difference between
female and male survival curves increased from birth, to
a maximum at age ∼80 years, and then decreased,
whereas the difference between the logarithms of sur-
vival functions continued increasing until age x100
years. Variation in the sex ratio was greatest not when
the difference between survivals was maximal but when
the overall survival was lowest. Equation (1) illustrates
this, showing that the frequency-ratio variation not only
followed the same trend as long as the difference be-
tween the respective mortality functions had the same
sign but also accelerated when this difference in-
creased—which was likely to occur as forces of mortality
increased sharply in the senescent-age range.
Gompertz-Makeham–Parameter Estimations for
Age-Specific Mortality Data
The age-specific mortality data (qx) for males, females,
and the overall population were separately fitted to the
Gompertz-Makeham model (eq. [10]). Adjustments
were made for ages spanning the range from 20 years
to either age 69 years or the maximum available age
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Figure 3 Change, with age, of the genotypic structure of an
heterogeneous cohort composed of three genotypes—AA, AB, and
BB—exhibiting Gompertz-Makeham mortality phenotypes. a, Fre-
quency trajectories of the three genotypes. b, Force-of-mortality curves
for the three genotypes AA, AB, and BB, modeled by Gompertz-Mak-
eham equations (for values of parameters, see text). c, Calculated co-
hort-mortality curve, observed 1990–92 overall-population mortality
data curve, and their difference, in logarithmic scale.
Figure 4 Fit of the genotypic data reported for the three gen-
otypes—DD, II, and ID—at the ACE locus in two age groups (adult
and centenarian), under Gompertz-Makeham equations for age-spe-
cific mortality. a, Frequency trajectories of genotypes DD, II, and ID.
Squares and circles denote, respectively, the observed and calculated
frequencies of the genotypes in the two age groups. b, Force-of-mor-
tality curves for genotypes II, DD, and ID, modeled by Gompertz-
Makeham equations (for values of parameters, see text). c, Calculated
cohort-mortality curve, observed 1990–92 overall-population mortal-
ity curve, and their difference, in logarithmic scale.
(age 106 years for men and age 109 years for women
and the overall population). Figure 2 displays the ob-
served and the adjusted Gompertz-Makeham curves for
the two sexes, as well as their difference. The best-fitting
sets of parameters were m  2.16 # 104, a  3.44#
105, and a  .0836, for females in the age range 20–69
years (fig. 2a) ; m  1.06 # 103, a  4.58 # 105,
and a  .0936, for males in the age range 20–69 years
(fig. 2b) ; m  3.88 # 104, a  1.06 # 105, and a
 .1038, for females in the age range 20–109 years (fig.
2c); and m  1.05 # 103, a  4.81 # 105, and a 
.0925, for males in the age range 20–106 years (fig. 2d).
It was possible to obtain a very good fit over the entire
life span, while a characteristic pattern of difference be-
tween the observed and modeled mortality curves ap-
peared for each sex. Women exhibited a definite increase
in the first derivative of log(qx) during the 8th decade
of life, corresponding to a “hump” in their logarithmic
mortality curve, at age ∼75–95 years, which was not
seen in men. The erratic variation of the difference curve
in men of age 1100 years reflected sampling fluctuations
that were due to the low number of available observa-
tions, the annual mortalities for centenarians being ex-
tracted from the Fondation IPSEN survey, which in-
cluded only 97 males (Allard et al. 1993). Whereas
parameters of the mortality function for men changed
slightly with the age range, those for women changed
markedly. The exponential coefficient and the initial
mortality were most affected, with an increase in the
former compensated by a decrease in the latter, account-
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ing for the mortality increase at age 170 years. As ex-
pected, the fitting procedure performed on mortalities
of the overall population (curves not shown) yielded
parameter estimations intermediate between those of
males and those of females: m  6.39# 104, a  4.13
# 105, and a  .0892) in the age range 20–69 years
and m 7.32# 104, a 2.94# 105, and a .0948)
in the age range 20–109 years.
Simple Genetic-Heterogeneity Model
We then considered a hypothetical locus with two al-
leles A and B acting on survival capacities. Because of
the lack of accurate genotype-specific survival-functions
data, we assumed that the force-of-mortality functions
of the three genotypes AA, BB, and AB conformed to
Gompertz-Makeham equations (eq. [11]) and that mAB(x)
was independent of mAA(x) and mBB(x), to allow for a
possible change in dominance, with age, for the mor-
tality phenotype.
Given the sole constraint that the initial distribution
of genotypic frequencies at age 20 years was in Hardy-
Weinberg equilibrium, the eight parameters of the model
were numerically adjusted by minimization of the de-
viations between the observed French-population mor-
tality curve and the resultant curve that the parameters
generated. The exploration of parameter space yielded
numerous sets of parameters compatible with mortality
data, depending on the initial genetic structure. Figure
3 shows an example of such adjustment. In this case,
the fitted values of the parameters were fA0 .894 (initial
frequency of allele A at age x0  20 years), m  6.45
# 104, aAA  4.54 # 10
5, aAA  .0908, aBB  6.76
# 104, aBB  .0571, aAB  9.22 # 10
9, and aAB 
.1890. The composition of the three genotype-specific
mortality functions resulted in an accurate fit to the real
data, as shown in figure 3c. Frequency trajectories are
shown in figure 3a: the frequency distribution remained
stable until age ∼70 years, changed smoothly at age
70–90 years, and thereafter underwent drastic changes.
The initially rare BB genotype eventually invaded the
population of late survivors. Genotype-specific mortality
curves intersected at age ∼85 years (fig. 3b). Many ad-
justments gave similar observations (data not shown):
(1) trajectories of genotypic frequencies showed a suc-
cession of peaks, with, at most, two maxima, although
more extrema were obtained when more genotypes per
cohort were considered; (2) greater difference in geno-
type frequency became evident with increasing age, par-
ticularly at age 190 years; and (3) mortality curves for
the different genotypes intersected at age 80–100 years.
Model Adjustment to ACE-Locus Data
ACE is a peptidase, cleaving, as its major substrates,
angiotensin I and bradykinin, two peptides important in
vascular-tone regulation (Cambien et al. 1994). There
exists in the ACE gene an I/D polymorphism, and the
D allele appears to be a risk factor for coronary artery
disease and myocardial infarction (Cambien et al. 1992).
Furthermore, a codominant effect of the two alleles is
observed with regard to this latter risk, as quantified by
odds ratios: 2.6 for DD versus II and 1.9 for ID versus
II (Tiret et al. 1993). Since circulatory diseases are a
leading cause of death, especially at advanced ages, the
frequency of D alleles should decrease in groups of in-
creasing age. Surprisingly, the D allele and DD geno-
types are more frequent in exceptionally long-lived in-
dividuals than in adult controls (Scha¨chter et al. 1994).
For adults in the 20–70-year age range, the odds ratios
of becoming centenarian were 0.51 for ID versus DD
and 0.90 for ID versus II, with respective 95% confi-
dence intervals of 0.33–0.79 and 0.54–1.50. The het-
erozygous genotype thus had a lower survival proba-
bility from middle to very old age, compared with both
homozygous genotypes, although the difference was not
statistically significant.
The model presented above was used to fit the ob-
served ACE genotypic frequencies in the adult group
(age 20–70 years) and the centenarian group. Figure 4
shows the frequency trajectories and the age-specific
mortality curves generated by the fittest set of parame-
ters: fI0  .440 (initial frequency of allele I at age x0 
20 years), m  5.46 # 104, aII  3.10 # 10
6, aII 
.1215, aDD  2.10# 10
4, aDD  .0735, aID  6.52#
106, and aID  .1127. The calculated relative risks of
death at age 50 years were 4.6, for DD versus II, and
1.3, for ID versus II. These values are consistent with
odds ratios for the risk of cardiovascular diseases (Tiret
et al. 1993). The DD genotype had a higher initial mor-
tality, accounting for its appearance as a risk factor for
adults until their late 80s, when its mortality function
intersected the others (fig. 4b). Thereafter, the DD ge-
notype’s frequency increased at the expense of the two
others’ (fig. 4a). As a result of potent mortality-driven
selection operating among genotypes at very old ages,
there was a marked reduction in the exponential increase
of mortality at the cohort level (fig. 4c). The cohort curve
converged toward the curve of the only remaining DD
genotype and fitted the mortality data at advanced ages.
The use of Gompertz-Makeham equations explained a
very rapid increase in DD genotypes. A modified model,
assuming linearly (rather than exponentially) increasing
mortality at age 190 years, led, with similar optimiza-
tion, to less dramatic changes at very old ages, although
the qualitative effect remained the same (data not
shown).
Discussion
By modeling how differential mortalities shape the
genetic composition of an aging cohort, we have revealed
striking properties. Our basic model of a heterogeneous
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cohort subdivided into genotypes differing in their mor-
tality functions showed the following: The ratio of any
two genotypic frequencies is a monotonic function of
age as long as the difference between their respective
mortality functions retains the same sign. Furthermore,
if these differences increase in absolute value, as was
found for French males and females, then frequency var-
iation accelerates with age. A frequency trajectory
reaches an extremum and reverses only when the as-
sociated mortality curve intersects the global mortality
curve. Therefore, dramatic changes in population struc-
ture may be expected as mortality increases as the pop-
ulation ages.
Our model employing genotype-specific mortality
functions in Gompertz-Makeham form uses independent
parameters, which allows mortality curves of different
genotypes to cross, indicating the existence of antago-
nistic pleiotropy for survival. Most previous models of
heterogeneous aging cohorts assumed that individuals
are born with a given relative age-independent suscep-
tibility to death, called “frailty” (Vaupel et al. 1979).
Individual forces of mortality are proportional to a stan-
dard hazard function, and the relative effect of an in-
dividual genotype on survival acts in the same direction
throughout life. Clearly, antagonistic pleiotropy for sur-
vival, at different ages, cannot occur in this framework.
In contrast, a simple cohort of individuals with three
genotypes at a biallelic locus A/B and having different
mortality functions revealed striking features of age-de-
pendent dynamics of genotype frequencies. First, genetic
composition may undergo dramatic changes with age,
such that a rare genotype rapidly becomes the most fre-
quent at age 1100 years, making it appear to be a “lon-
gevity genotype.” Second, age-dependent antagonistic
pleiotropy for survival does occur when mortality curves
intersect at an advanced age. We suggest that this in-
tersection is the result of our fitting procedure using
Gompertz-Makeham equations to model age-specific
mortalities. The adult-mortality curve of the French pop-
ulation exhibits a triphasic shape: an initial phase, which
can be accurately fitted by a unique Gompertz-Makeham
equation for ages 20–70 years; a second phase of ac-
celeration in the mortalities, which increases in the age
range of 70–90 years; and a third phase, of deceleration,
for ages 190 years. Sets of Gompertz-Makeham curves
accounting for this pattern would then correspond to at
least two crossing curves, one curve mainly accounting
for the initial phase and one curve mainly accounting
for the final phase. A modified mortality model, assum-
ing linearly rather than exponentially increasing rates at
age 190 years, yields similar adjustments. This tends to
strengthen this result.
Antagonistic pleiotropy in evolutionary theory usually
refers to opposite effects of a genotype on fecundity and
survival (Rose 1985; Kirkwood and Rose 1991). The
existence of trade-offs between these two components
of Darwinian fitness was proposed to explain the evo-
lution of senescence and the maintenance, via the cre-
ation of a heterozygous advantage, of polymorphism at
loci involved in the determination of both traits. In our
model, antagonistic pleiotropy involves, instead, relative
survival values of a genotype at different ages, as orig-
inally proposed by Williams (1957). However, given the
very late ages at which mortality curves intersect in our
examples, the antagonistic effects on survival are un-
likely to contribute to the net fitness of genotypes, as a
consequence of the neutrality of genetic effects expressed
at advanced ages (Hamilton 1966; Charlesworth 1980).
Because age-specific mortality at age !20 years cannot
be modeled by Gompertz-Makeham equations, our
model assumes that genotypes have identical probabil-
ities of survival to this age. Furthermore, given that the
genotype-independent background mortality is the ma-
jor parameter determining the value of mortalities for
young age classes and that mortalities are relatively low
in the reproductive period, the genetic heterogeneity in
mortalities is probably quasi-neutral with regard to nat-
ural selection.
In our model, antagonistic pleiotropy for survival is
the result of crossing mortality functions conforming to
Gompertz-Makeham equations. Analyses of life tables
from many human populations reveal that age-specific
mortality curves appear to converge to the same age,
referred to as the “species-specific life span,” l (Gavrilov
and Gavrilova 1991). We suggest that l, estimated as
being 95 years for humans, represents a point of reversal,
since any genotype that has an effect on survival prior
to this age would exhibit the opposite effect after this
age. This may provide an explanation for puzzling re-
sults for HLA-DR, in which, for some alleles, significant
differences between nonagenarians and centenarians are
found (Ivanova et al. 1998). Antagonistic pleiotropy for
survival would thus be a general rule, although some
exceptions, such as mutations causing early-onset dis-
eases, certainly exist.
Most interestingly, this model accounts for data con-
sidered paradoxical, including the increased frequency
of the “risk-associated” ACE/DD genotype in cente-
narians. This genotype is associated with common my-
ocardial infarction, dilated cardiopathy, and sudden
death (Marian et al. 1993; Schunkert et al. 1994). The
latter phenotype, with hypertrophy of the left ventricle,
mimics the natural state of very aged hearts (Hammond
et al. 1971; Gunby 1995), suggesting that an age-related
adaptation may occur that is favored by the ACE/D
allele. Moreover, Chagas disease patients display similar
features, and those who escape early death live longer
than controls. Genotyping such patients, as well as eld-
erly athletes who have also undergone intensive cardiac
adaptation, could add support to the purported age-
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related adaptive role of the ACE/D allele. This illustrates
one example of antagonistic pleiotropy for survival.
Changes in APOE/4 allele frequencies in cohorts of dif-
ferent ages (Poirier et al. 1993), as well as varying fre-
quencies of different HLA alleles in elderly populations
(Proust et al. 1982; Takata et al. 1987), could also be
interpreted in this light.
The range of Gompertz-Makeham parameters found
in our adjustments may seem unrealistically large. How-
ever, even more extreme values have been proposed to
fit complex mortalities (Kowald and Kirkwood 1993;
Vaupel and Carey 1993). Furthermore, Gompertzian
parameters exhibiting as much as a fourfold difference
in exponential coefficient and as much as a one-order-
of-magnitude difference in initial mortalities have been
found for different genotypes in Caenorhabditis elegans
(Johnson 1990). Human genetic conditions such as
Down syndrome or muscular dystrophy have large ef-
fects on survival. Altogether, these data appear to sup-
port the existence of a genetic component to the rate of
change of age-dependent mortality, rather than only to
the susceptibility to age-related pathologies. This has
been suggested for Drosophila (Hughes and Charles-
worth 1994) and C. elegans (Johnson 1987; Kenyon et
al. 1993). It may be argued that our knowledge of age-
related pathologies in D. melanogaster or in C. elegans
is yet very scant. Relevant to the thorny issue of distin-
guishing between hypothetical “intrinsic” aging and age-
related pathology is the “compensation effect” described
by Gavrilov and Gavrilova (1991), whereby mortality
effects due to different diseases compensate for each
other. Pathological causes of mortality in various pop-
ulations appear to fall into categories interrelated by
positive or negative correlations. Our model, per se, does
not allow us to differentiate between mortality due to
“aging” and that due to disease.
Whether the Gompertz law generally holds at very old
ages is unclear, since several studies have found that
mortality levels off toward the end of the life span (Carey
et al. 1992; Curtsinger et al. 1992). Two reasons may
explain this observation. First, after the turning point
where mortality curves intersect, those genotypes with
low mortality increase in frequency, thereby decreasing
the resultant acceleration in mortality (Kowald and
Kirkwood 1993; Vaupel and Carey 1993), as illustrated
in figures 3c and 4c. Second, individuals may adapt to
their own aging. Mortality functions result from the in-
crease in individual vulnerability with advancing years,
under the assumption that levels of environmental stress
remain constant. However, aging persons may reduce
environmental perturbations, by decreasing movement,
food ingestion, etc. For example Jeanne Calment, who
died in 1997 at age 123 years, was motionless and ate
almost nothing in her last years, thus reducing her basal
metabolism. This effect of adaptation to aging could
attenuate the differences in mortalities among genotypes,
while also contributing to an overall reduction of mor-
tality increase near the end of the life span.
Our model clearly shows that simple mathematical
equations can generate complex changes in gene fre-
quency over short age intervals near the end of life,
which has consequences on the sampling strategy for
studies of genetic factors influencing survival. This
model may provide a bridge between demography and
quantitative genetics, fields generally considered sepa-
rate, allowing formulation of a comprehensive theory of
aging (McClearn 1987, 1997). The widespread notions
of “risk factor” and “relative risk” should be reap-
praised, with account being taken of their age depen-
dence. Finally, antagonistic pleiotropy for survival, re-
sulting from crossing mortality curves, suggests that,
although the reverse has been widely assumed, the ge-
netics of late survival may well shed light on the genetics
of age-related pathologies.
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